MORE posts
Based on a recent study, our team has published an article in the “PAINWeek Journal” titled, “Disability Claimants and the Implementation of a Web-based Pain Assessment/Pain Management Program.” For more information about this study, please see the abstract below. To obtain the full article, click here. Abstract One of the most frustrating aspects of a clinician’s work is getting […]
Based on a recent study, our team has published an article in the “Journal of Opioid Management” titled, “Abuse of reformulated OxyContin: Updated findings from a sentinel surveillance sample of individuals assessed for substance use disorder.” For more information about this study, please see the abstract below. To obtain the full article, click here. Abstract Objective: To examine abuse […]
Taryn Dailey-Govoni, Jared Beaumont, Theresa Cassidy Inflexxion, Inc., Waltham, MA, USA Presented at PAINWeek 2017 Read our poster for “Profiling non-medical use of tapentadol products among recreational drug abusers” here Abstract Purpose Prescription opioid misuse and abuse is a public health epidemic in the United States (ONDCP 2015) and a growing source of morbidity, mortality, […]
Click here to read our latest article, The Power of an Electronic Clinical Assessment for Pain and Opioid Misuse Risk: Leveraging SOAPP & COMM in a Digital Era
Inflexxion, Inc. announced today that Allscripts has certified PainCAS™ as part of the Allscripts Developer Program. PainCAS enables Allscripts ambulatory EHR users to assess pain, functioning, and risk of problematic opioid-related behaviors in patients with chronic pain. Developed in part with support from the National Institutes of Health (NIH), grants (Grant No. R44DA026359, PI S.F. Butler and Grant No. R44DA015617, PI S.F. Butler), PainCAS is a scientifically validated web-based, patient self-report clinical tool for assessing pain and opioid misuse risk in patients with chronic pain.
Jared Beaumont, M.P.H.1, Theresa Cassidy, M.P.H.1, Taryn Dailey Govoni, M.P.H.1 Presented at International Conference on Opioids 2017 See our poster for “Abuse and route of administration prevalence for tapentadol products within the NAVIPPRO® ASI-MV® surveillance system” here Abstract Post-market surveillance data indicate low abuse levels of tapentadol products, but research regarding the route of administration […]
Kimberlee J. Trudeau, Joanna Burtner, Kruti Joshi, Albert Villapiano, Megan Jones, & Stephen F. Butler Presented at ARM 2016 See our poster for “A Cross-Sectional Analysis of Economic, Medical, and Legal Outcomes of Adults in Substance Abuse Treatment centers with Possible or Probable Schizophrenia” here Research Objective: In the fragmented US healthcare system, patients seeking substance abuse […]
Theresa A. Cassidy, MPH, Natasha K. Oyedele, MPH, Jared Beaumont, MPH, Stephen F. Butler, PhD Presented at PAINWeek 2015 See our poster for “Patterns of abuse of hydrocodone combination products: Results from an Internet survey of recreational drug users” here Summary: Researchers conducted this study to examine the progression of hydrocodone combination products (HCP) abuse, routes of administration, and […]
Theresa A. Cassidy, Jared Beaumont, Veronica Urdaneta, Simon H. Budman, Stephen F. Butler Presented at PAINWeek 2014 See our poster for “The changing abuse ecology: implications for evaluating the abuse pattern of extended-release oxymorphone and abuse-deterrent opioid formulations” here Abstract Purpose FDA Guidelines released in January 2013 on evaluating abuse-deterrent formulations (ADFs) recommend direct comparison […]
Stephen F. Butler, PhD, Theresa A. Cassidy, MPH, Taryn Dailey, BA1, & Paul M. Coplan, ScD2, Presented at CPDD 2014 See our poster for “Comparing abuse of extended-release versus immediate-release opioid analgesics adjusted for number of prescriptions and morphine-equivalent dose” here Abstract Aims: It has been suggested that abuse risk of extended-release (ER) opioids is […]
Theresa A. Cassidy, MPH, Simon H. Budman, PhD, Stephen F. Butler, PhD Presented at CPDD 2014 See our poster for “Evaluation of an ADF product’s route of administration profile” here Abstract Aims: Assessing the impact on abuse patterns of the introduction of abuse deterrent opioid formulations (ADFs) has focused, in part, on comparisons of the […]
Based on a recent study, our team has published an article in “Pain Medicine” titled, “How does use of a prescription monitoring program change medical practice?” To access the full text, click here. Abstract OBJECTIVES: To assess differences in prescription monitoring program (PMP) use between two states with different PMP accessibility (Connecticut [CT] and Rhode […]